@article{7680e67363674bdf98702089febd6098,
title = "Characteristics and Longitudinal Patterns of Erectile Dysfunction Drug Use Among Men Who Have Sex with Men in the U.S.",
abstract = "We investigated the longitudinal relationship between erectile dysfunction (ED) drug use with behavioral factors, including substance use and sexual activities in men who have sex with men from the Multicenter AIDS Cohort Study during 1998–2016 (n = 1636). We used a bivariate random-intercept model to evaluate ED drug use along with other behavioral factors to assess relationships between the two outcomes over time on a population level and also at the individual level. Average ED drug use among men who have sex with men (MSM) with HIV was positively correlated with average use of marijuana (r =.19), poppers (r =.27), and stimulants (r =.25). In this group, testosterone use (r =.32), multiple partners (r =.41), insertive anal intercourse with condom (r =.40), and insertive anal intercourse without condom (r =.43) all showed moderate correlations over time with average ED use (p <.001). Associations among MSM without HIV were similar, with average marijuana use (r =.19) and stimulant use (r =.22) being positively correlated with average ED drug use, and were also correlated with having multiple partners (r =.36), insertive anal intercourse with condom (r =.22), and insertive anal intercourse without condom (r =.18) over time. Positive within-individual associations between ED drug use and multiple partners and insertive anal intercourse with and without condom were observed regardless of HIV serostatus. This study showed that MSM who reported use of ED drugs were also, on average, more likely to use recreational drugs and engage in sexual activities, such as having multiple partners and insertive anal intercourse. Within individuals, average ED drug use was also positively correlated with sexual behaviors.",
keywords = "HIV, Multivariate analysis, Phosphodiesterase 5 inhibitors, Recreational drugs, Sexual behavior, Sexual orientation",
author = "Park, {Jee Won} and Dobs, {Adrian S.} and Ho, {Ken S.} and Palella, {Frank J.} and Seaberg, {Eric C.} and Weiss, {Robert E.} and Roger Detels",
note = "Funding Information: Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS), now the MACS/WIHS Combined Cohort Study (MWCCS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). Baltimore CRS (Todd Brown and Joseph Margolick), U01-HL146201-01; Chicago-Northwestern CRS (Steven Wolinsky), U01-HL146240-01; Los Angeles CRS (Roger Detels), U01-HL146333-01; Pittsburgh CRS (Jeremy Martinson and Charles Rinaldo), U01-HL146208-01; Data Analysis and Coordination Center (Gypsyamber D{\textquoteright}Souza, Stephen Gange and Elizabeth Golub), U01-HL146193-01. The MACS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH). Targeted supplemental funding for specific projects was also provided by the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Deafness and Communication Disorders (NIDCD). MACS data collection is also supported by UL1-TR001079 (JHU ICTR) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, and NIH Roadmap for Medical Research. Funding Information: This work was supported by NIH U01-AI35042, U01-AI35039, U01-AI35040, U01-AI35041, UM1-AI35043, UL1-TR001079 (JHU ICTR) from the National Center for Advancing Translational Sciences (NCATS). This work was also supported by the Center for HIV Identification, Prevention, and Treatment (CHIPTS) NIMH grant P30MH058107. Funding Information: Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS), now the MACS/WIHS Combined Cohort Study (MWCCS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). Baltimore CRS (Todd Brown and Joseph Margolick), U01-HL146201-01; Chicago-Northwestern CRS (Steven Wolinsky), U01-HL146240-01; Los Angeles CRS (Roger Detels), U01-HL146333-01; Pittsburgh CRS (Jeremy Martinson and Charles Rinaldo), U01-HL146208-01; Data Analysis and Coordination Center (Gypsyamber D?Souza, Stephen Gange and Elizabeth Golub), U01-HL146193-01. The MACS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH). Targeted supplemental funding for specific projects was also provided by the?National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Deafness and Communication Disorders (NIDCD). MACS data collection is also supported by UL1-TR001079 (JHU ICTR) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, and NIH Roadmap for Medical Research. Publisher Copyright: {\textcopyright} 2021, The Author(s).",
year = "2021",
month = oct,
doi = "10.1007/s10508-021-02065-x",
language = "English (US)",
volume = "50",
pages = "2887--2896",
journal = "Archives of Sexual Behavior",
issn = "0004-0002",
publisher = "Springer New York",
number = "7",
}